Description
PP-121 an inhibitor of p110α PI3K, DNA-PK, mTORC1/2, Abl, Hck, Src, VEGFR2, and PDGFR that exhibits anticancer activity by inhibiting cellular proliferation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
PP-121 an inhibitor of p110α PI3K, DNA-PK, mTORC1/2, Abl, Hck, Src, VEGFR2, and PDGFR that exhibits anticancer activity by inhibiting cellular proliferation.
| Cas No. | 1092788-83-4 |
|---|---|
| Purity | ≥98% |
| Formula | C17H17N7 |
| Formula Wt. | 319.36 |
| IUPAC Name | 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[3,4-d]pyrimidin-4-amine |
| Solubility | DMSO 64 mg/mL (200.4 mM) Ethanol 2 mg/mL (6.26 mM) Water Insoluble |
| Appearance | White Crystal Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Apsel B, Blair JA, Gonzalez B, et al. Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat Chem Biol. 2008 Nov;4(11):691-9. PMID: 18849971.
Sartan
Endogenous secondary bile acid.
ACE inhibitor.
Alkaloid found in Catharanthus, precursor in sy...
Phenylethanoid glycoside found in Echinacea.
Insecticide; α-adrenergic agonist, MAO inhibit...
Benzamide; HDAC1 inhibitor.
Paclitaxel derivative
ALK and IGF-1R inhibitor.
Protein translocation inhibitor.
c-Raf, Ret, VEGFR2 inhibitor, potential STAT3/5...
Vitamin B6 derivative, antioxidant.
p110δ and p110γ PI3K inhibitor.
Bisphosphonate.
AT1 inhibitor.
MEK1/2 and ERK inhibitor.
Thienylbutyl ITC analog.
Butyrophenone; σ2 agonist, α1-adrenergic, D2,...
Endogenous pteridine metabolite of GTP.
Endogenous peptide, involved in stress signalin...